1. Accueil
  2. Marc Arbyn
  3. Marc Arbyn

Onglets principaux

Rechercher
Limit to
Exporter 219 resultats:
Filtres: Auteur is M. Arbyn
2025
Directive Clinique : Soutenant l'introduction du test HPV pour le dépistage du cancer du col de l'utérus en Belgique, Simoens, Cindy, Arbyn M., Dr. Gilles Christine, and Dewilde Dr. Kobe , Brussel, p.33, (2025)
2024
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework., Chung, Pui Yan Jenny, Dhillon Sharon, Simoens Cindy, Cuypers Lize, Laenen Lies, Bonde Jesper, Corbisier Philippe, Buttinger Gerhard, Cocuzza Clementina E., Van Gucht Steven, et al. , Microbiol Spectr, 2024 Jan 08, (2024)
Clinical Guidance: Supporting the introduction of the HPV test in cervical cancer screening in Belgium, Simoens, Cindy, Arbyn M., Dr. Gilles Christine, and Dewilde Dr. Kobe , (2024)
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework., Cocuzza, Clementina Elvezia, Dhillon Sharon, Martinelli Marianna, Giubbi Chiara, Chinyere Njoku, Ruth, Bhatia Ramya, Cuschieri Kate, and Arbyn M. , Int J Cancer, 2024 Feb 01, Volume 154, Issue 3, (2024)
Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance, Prétet, Jean Luc, Arroyo Mühr Laila Sara, Cuschieri Kate, Fellner María Dolores, Correa Rita Mariel, Picconi María Alejandra, Garland Suzanne M., Murray Gerald L., Molano Monica, Peeters Michael, et al. , Journal of Clinical Virology, Jan-04-2024, Volume 171, (2024)
Klinische toelichting: Ter ondersteuning van de invoering van de HPV-test voor screening naar baarmoederhalkanker in België, Arbyn, M., and Simoens Cindy , Brussels, Belgium, (2024)
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer, Arbyn, M., Rousta P., Bruni Laia, Schollin Ask Lina, and Basu Partha , JNCI: Journal of the National Cancer Institute, Jul-03-2025, (2024)
Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg, Nyaga, Victoria N., and Arbyn M. , Archives of Public Health, 29/01/2024, Volume 82, (2024)
Validated HPV tests usable in cervical cancer screening on clinician-collected cervical specimens, Arbyn, M., Dhillon Sharon, and Poljak Mario , www.HPVWorld.com, Issue 270, (2024)
2023
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services, Le Goff, Johane, Le Duc-Banasz Anne-Sophie, Lefeuvre Caroline, Pivert Adeline, Ducancelle Alexandra, De Pauw H, Arbyn M., Vinay Aubeline, and Rexand-Galais Franck , Cancers, Jan-11-2023, Volume 15, Issue 21, (2023)
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis., Downham, Laura, Jaafar Iman, Rol Mary Luz, Nyaga Victoria N., Valls Joan, Baena Armando, Li Zhang, Gunter Marc J., Arbyn M., and Almonte Maribel , Br J Cancer, 2023 Nov 16, (2023)
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol., Dhillon, Sharon, Simoens Cindy, Cuypers Lize, Bode Jannes, Bonde Jesper, Corbisier Philippe, Cocuzza Clementina E., Van Ranst Marc, and Arbyn M. , Virol J, 2023 Feb 24, Volume 20, Issue 1, (2023)
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV., Hall, Michaela T., Simms Kate T., Murray John M., Keane Adam, Nguyen Diep T. N., Caruana Michael, Lui Gigi, Kelly Helen, Eckert Linda O., Santesso Nancy, et al. , Nat Med, 2023 Dec, Volume 29, Issue 12, (2023)
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population., Simms, Kate T., Keane Adam, Ngoc Nguyen, Diep Thi, Caruana Michael, Hall Michaela T., Lui Gigi, Gauvreau Cindy, Demke Owen, Arbyn M., Basu Partha, et al. , Nat Med, 2023 Dec, Volume 29, Issue 12, (2023)
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?, Arbyn, M., Cuschieri Kate, Poljak Mario, and Bonde Jesper , Clin Microbiol Infect, 2023 Dec, Volume 29, Issue 12, (2023)
Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening., Arbyn, M., Rousta P., Dhillon Sharon, Gultekin M., and Cuschieri K. , ESGO Textbook of Gynaecological Oncology, Number 120, (2023)
Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol., Latsuzbaia, Ardashel, Van Keer Severien, Broeck Davy Vanden, Weyers Steven, Donders Gilbert, De Sutter Philippe, Tjalma Wiebren, Doyen Jean, Vorsters Alex, and Arbyn M. , J Mol Diagn, 2023 Dec, Volume 25, Issue 12, (2023)
Comparison and validation of metadta for meta-analysis of diagnostic test accuracy studies., Nyaga, Victoria N., and Arbyn M. , Res Synth Methods, 2023 May, Volume 14, Issue 3, (2023)
Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework., Latsuzbaia, Ardashel, Broeck Davy Vanden, Van Keer Severien, Weyers Steven, Donders Gilbert, Doyen Jean, Tjalma Wiebren, De Sutter Philippe, Vorsters Alex, and Arbyn M. , J Mol Diagn, 2023 Sep, Volume 25, Issue 9, (2023)
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?, Kamani, Mustafa Onur, Kyrgiou Maria, Joura Elmar, Zapardiel Ignacio, Grigore Mihaela, Arbyn M., Preti Mario, Planchamp François, and Gultekin Murat , Int J Gynecol Cancer, 2023 Apr 03, Volume 33, Issue 4, (2023)
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework., Dhillon, Sharon, Cocuzza Clementina E., Chung Pui Yan Jen, Martinelli Marianna, Giubbi Chiara, Njoku Ruth C., Bhatia Ramya, Cuschieri Kate, and Arbyn M. , J Med Virol, 2023 Jan, Volume 95, Issue 1, (2023)
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework, Dhillon, Sharon, Cocuzza Clementina E., Pui Yan Chung Jenny, Martinelli Marianna, Giubbi Chiara, Njoku Ruth C., Bhatia Ramya, Cuschieri Kate, and Arbyn M. , Journal of Medical Virology, Jan-01-2023, Volume 95, Issue 1, (2023)
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis., Bruni, Laia, Albero Ginesa, Rowley Jane, Alemany Laia, Arbyn M., Giuliano Anna R., Markowitz Lauri E., Broutet Nathalie, and Taylor Melanie , Lancet Glob Health, 2023 Sep, Volume 11, Issue 9, (2023)
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative., Singh, Deependra, Vignat Jerome, Lorenzoni Valentina, Eslahi Marzieh, Ginsburg Ophira, Lauby-Secretan Beatrice, Arbyn M., Basu Partha, Bray Freddie, and Vaccarella Salvatore , Lancet Glob Health, 2023 Feb, Volume 11, Issue 2, (2023)
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial., Glinska, Patrycja, Komerska Katarzyna, Janik Beata, Olkowicz Julia, Jedrzejewska Ilona, Macios Anna, Wieszczy Paulina, Kaminski Michal F., Arbyn M., and Nowakowski Andrzej , BMC Cancer, 2023 Nov 17, Volume 23, Issue 1, (2023)

QR code

QR code for this page URL